5.0
11. Dez. 2023
Aktueller Mitarbeiter, mehr als 3 Jahre
Scottsdale, AZ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
TD2 takes a different approach to client projects - science-led and with the view of the entire drug development ecosystem in mind. This is reflected and appreciated in client conversations and relationship with the BD team.
Kontras
TD2 is a growing company and may not always have the latest technology or resources as a big CRO.